Panvascular Disease: Opportunities and Challenges
iNew Medicine · 2025-12 · 1 (1)
DOI: 10.1002/inm3.70001 ↗Kurz gefasst
Fachartikel in der Zeitschrift iNew Medicine, online erschienen am 06.11.2025. Verfasst von Zhixing Li und 2 weiteren Autor:innen. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Panvascular disease (PVD) is a systemic manifestation of atherosclerosis involving multiple vascular beds, such as coronary, cerebral, peripheral, and renal arteries. It is increasingly recognized as a high‐risk condition due to the synergistic burden of multibed involvement. Despite growing awareness, clinical care and research remain fragmented. This article explores PVD from epidemiologic, pathophysiologic, diagnostic, and therapeutic perspectives and proposes a structured framework to guide future innovation and integration. We introduce the PANVD strategy, identifying five core opportunities to advance systemic care: personalized risk stratification and biomarkers, AI‐driven digital health tools, networked multispecialty care teams, vascular technology translation across arterial beds, and data‐driven population strategies and registries. Together, these interconnected priorities offer a roadmap for transforming panvascular care from reactive and siloed to proactive, precise, and patient‐centered.
Zitieren
APA
Li, Z., Dai, Y., & Ge, J. (2025). Panvascular Disease: Opportunities and Challenges. iNew Medicine, 1(1). https://doi.org/10.1002/inm3.70001
Vancouver
Li Z, Dai Y, Ge J. Panvascular Disease: Opportunities and Challenges. iNew Medicine. 2025;1(1). doi:10.1002/inm3.70001
BibTeX
@article{Li2025,
author = {Li, Zhixing and Dai, Yuxiang and Ge, Junbo},
title = {Panvascular Disease: Opportunities and Challenges},
journal = {iNew Medicine},
year = {2025},
volume = {1},
number = {1},
doi = {10.1002/inm3.70001}
}
EUVIMED